Top Banner
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 2359 2359 JP XVII Ultraviolet-visible Reference Spectra Oxytocin Ozagrel Sodium Panipenem
47

Oxytocin - Pmda

Dec 10, 2021

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23592359JP XVII Ultraviolet-visible Reference Spectra

Oxytocin

Ozagrel Sodium

Panipenem

Page 2: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23602360 JP XVIIUltraviolet-visible Reference Spectra

Paroxetine Hydrochloride Hydrate

Pemirolast Potassium

Penbutolol Sulfate

Page 3: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23612361JP XVII Ultraviolet-visible Reference Spectra

Pentazocine

Peplomycin Sulfate

Perphenazine 1

Page 4: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23622362 JP XVIIUltraviolet-visible Reference Spectra

Perphenazine 2

Perphenazine Maleate 1

Perphenazine Maleate 2

Page 5: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23632363JP XVII Ultraviolet-visible Reference Spectra

Pethidine Hydrochloride

Phenethicillin Potassium

Phenobarbital

Page 6: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23642364 JP XVIIUltraviolet-visible Reference Spectra

Phenolsulfonphthalein

Phenylbutazone

Phytonadione 1

Page 7: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23652365JP XVII Ultraviolet-visible Reference Spectra

Phytonadione 2

Pilsicainide Hydrochloride Hydrate

Pimaricin

Page 8: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23662366 JP XVIIUltraviolet-visible Reference Spectra

Pimozide

Pindolol

Pioglitazone Hydrochloride

Page 9: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23672367JP XVII Ultraviolet-visible Reference Spectra

Pipemidic Acid Hydrate

Pirarubicin

Pirenoxine

Page 10: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23682368 JP XVIIUltraviolet-visible Reference Spectra

Pirenzepine Hydrochloride Hydrate

Piroxicam

Pitavastatin Calcium Hydrate

Page 11: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23692369JP XVII Ultraviolet-visible Reference Spectra

Potassium Canrenoate

Potassium Clavulanate

Potassium Guaiacolsulfonate

Page 12: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23702370 JP XVIIUltraviolet-visible Reference Spectra

Pranlukast Hydrate

Pranoprofen

Pravastatin Sodium

Page 13: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23712371JP XVII Ultraviolet-visible Reference Spectra

Prazepam

Prazosin Hydrochloride

Prednisolone Sodium Phosphate

Page 14: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23722372 JP XVIIUltraviolet-visible Reference Spectra

Probenecid

Probucol

Procaine Hydrochloride

Page 15: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23732373JP XVII Ultraviolet-visible Reference Spectra

Procarbazine Hydrochloride

Procaterol Hydrochloride Hydrate

Progesterone

Page 16: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23742374 JP XVIIUltraviolet-visible Reference Spectra

Promethazine Hydrochloride

Propafenone Hydrochloride

Propiverine Hydrochloride

Page 17: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23752375JP XVII Ultraviolet-visible Reference Spectra

Propranolol Hydrochloride

Pyrantel Pamoate

Pyrazinamide

Page 18: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23762376 JP XVIIUltraviolet-visible Reference Spectra

Pyridostigmine Bromide

Pyridoxine Hydrochloride

Pyrrolnitrin

Page 19: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23772377JP XVII Ultraviolet-visible Reference Spectra

Quetiapine Fumarate

Quinapril Hydrochloride

Quinine Ethyl Carbonate

Page 20: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23782378 JP XVIIUltraviolet-visible Reference Spectra

Quinine Sulfate Hydrate

Rabeprazole Sodium

Ranitidine Hydrochloride

Page 21: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23792379JP XVII Ultraviolet-visible Reference Spectra

Rebamipide

Reserpine

Ribavirin

Page 22: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23802380 JP XVIIUltraviolet-visible Reference Spectra

Riboflavin

Riboflavin Butyrate

Riboflavin Sodium Phosphate

Page 23: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23812381JP XVII Ultraviolet-visible Reference Spectra

Rifampicin

Risperidone

Ritodrine Hydrochloride

Page 24: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23822382 JP XVIIUltraviolet-visible Reference Spectra

Rokitamycin

Roxatidine Acetate Hydrochloride

Salazosulfapyridine

Page 25: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23832383JP XVII Ultraviolet-visible Reference Spectra

Salbutamol Sulfate

Salicylic Acid

Santonin

Page 26: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23842384 JP XVIIUltraviolet-visible Reference Spectra

Sarpogrelate Hydrochloride

Scopolamine Butylbromide

Silodosin

Page 27: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23852385JP XVII Ultraviolet-visible Reference Spectra

Simvastatin

Sivelestat Sodium Hydrate

Sodium Cromoglicate

Page 28: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23862386 JP XVIIUltraviolet-visible Reference Spectra

Sodium Picosulfate Hydrate

Sodium Risedronate Hydrate

Spiramycin Acetate

Page 29: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23872387JP XVII Ultraviolet-visible Reference Spectra

Spironolactone

Sulindac

Sulpiride

Page 30: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23882388 JP XVIIUltraviolet-visible Reference Spectra

Sultiame

Tacalcitol Hydrate

Tamoxifen Citrate

Page 31: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23892389JP XVII Ultraviolet-visible Reference Spectra

Tamsulosin Hydrochloride

Tegafur

Telmisartan

Page 32: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23902390 JP XVIIUltraviolet-visible Reference Spectra

Temocapril Hydrochloride

Terbinafine Hydrochloride

Terbutaline Sulfate

Page 33: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23912391JP XVII Ultraviolet-visible Reference Spectra

Testosterone Propionate

Tetracaine Hydrochloride

Tetracycline Hydrochloride

Page 34: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23922392 JP XVIIUltraviolet-visible Reference Spectra

Theophylline

Thiamine Chloride Hydrochloride

Thiamylal Sodium

Page 35: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23932393JP XVII Ultraviolet-visible Reference Spectra

Tiapride Hydrochloride

Timepidium Bromide Hydrate

Timolol Maleate

Page 36: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23942394 JP XVIIUltraviolet-visible Reference Spectra

Tinidazole

Tipepidine Hibenzate

Tizanidine Hydrochloride

Page 37: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23952395JP XVII Ultraviolet-visible Reference Spectra

Tocopherol Nicotinate

Todralazine Hydrochloride Hydrate

Tofisopam

Page 38: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23962396 JP XVIIUltraviolet-visible Reference Spectra

Tolazamide

Tolnaftate

Tosufloxacin Tosilate Hydrate

Page 39: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23972397JP XVII Ultraviolet-visible Reference Spectra

Tranilast

Trapidil

Trepibutone

Page 40: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23982398 JP XVIIUltraviolet-visible Reference Spectra

Triamcinolone Acetonide

Triamterene

Trichlormethiazide

Page 41: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

23992399JP XVII Ultraviolet-visible Reference Spectra

Trimebutine Maleate

Trimetazidine Hydrochloride

Trimetoquinol Hydrochloride Hydrate

Page 42: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24002400 JP XVIIUltraviolet-visible Reference Spectra

Troxipide

Tulobuterol

Tulobuterol Hydrochloride

Page 43: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24012401JP XVII Ultraviolet-visible Reference Spectra

L-Tyrosine

Ubenimex

Ulinastatin

Page 44: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24022402 JP XVIIUltraviolet-visible Reference Spectra

Urapidil

Valaciclovir Hydrochloride

Valsartan

Page 45: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24032403JP XVII Ultraviolet-visible Reference Spectra

Vancomycin Hydrochloride

Verapamil Hydrochloride

Vinblastine Sulfate

Page 46: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24042404 JP XVIIUltraviolet-visible Reference Spectra

Vincristine Sulfate

Voriconazole

Warfarin Potassium

Page 47: Oxytocin - Pmda

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

24052405JP XVII Ultraviolet-visible Reference Spectra

Zaltoprofen

Zolpidem Tartrate